Genomics Software Market Forecast 2025: Competitive Landscape, Leading Vendors, and Strategic Developments in Genomic Technologies

LOS ANGELES, United States: The research study is a highly useful tool in the hands of market players that allows them to effectively assess the global Genomics Software market and know where they stand in the industry in terms of revenue or sales growth. It comprehensively evaluates the global Genomics Software market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.

The global market for Genomics Software was estimated to be worth US$ 311 million in 2024 and is forecast to a readjusted size of US$ 533 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.

Get PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.in/request-sample/service-software-genomics-software-global-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Global core genomics software players include Agilent Technologies, QIAGEN Digital Insights, SAS (JMP Genomics) etc. The largest company hold a share about 35%. North America is the largest market, with a share about 53%, followed by Europe and Asia-Pacific with the share about 24% and 19%.

In terms of product, on-premise is the largest segment, with a share over 78%. And in terms of application, the largest application is hospitals and health systems, followed by research organizations.

Market Drivers

Advancements in Next-Generation Sequencing (NGS) Technologies: Declining costs of DNA sequencing (e.g., Illumina, PacBio, Oxford Nanopore) drive demand for bioinformatics tools to analyze large datasets. Long-read sequencing and single-cell sequencing require advanced software for data processing.

Increasing Demand for Precision Medicine & Personalized Healthcare: Cancer genomics, pharmacogenomics, and rare disease research rely on genomics software for variant analysis. Clinical decision support tools integrate genomic data into patient care (e.g., IBM Watson Genomics, Tempus).

Growth of AI and Machine Learning in Genomics: AI-powered variant calling, genome annotation, and drug discovery (e.g., DeepVariant, DNAnexus). Predictive analytics for disease risk assessment and treatment optimization.

Market Segments

The global Genomics Software market is segmented on the basis of type of product, application, and region. The analysts authoring the report provide a meticulous evaluation of all of the segments included in the report. The segments are studied keeping in view their market share, revenue, market growth rate, and other vital factors. The segmentation study equips interested parties to identify high-growth portions of the global Genomics Software market and understand how the leading segments could grow during the forecast period.

Details of Genomics Software Market Segmentation: -

Segment by Key Manufacturers:

Agilent Technologies
SAS (JMP Genomics)
Thermo Fisher Scientific
QIAGEN Digital Insights
DNASTAR
Fabric Genomics
Biomatters (Geneious)
Illumina
DNAnexus
Bionano
Golden Helix
10x Genomics

Segment by Type

On-Premise
Cloud Based

Segment by Application

Hospitals and Health Systems
Research Organizations
Others

This is one of the most important sections of the research study as it provides deep insights into the growth of the Genomics Software market at both country and regional level. The researchers estimate market growth in different regions and countries by both value and volume. They accurately calculate the revenue, price, CAGR, consumption, sales, and other factors related to the regional markets studied here.

How will the report be a powerful addition to your resources?

The all-inclusive analysis of the global Genomics Software market provided in the research study can accelerate the decision-making process of players as it offers a clear explanation of market growth threats, opportunities, development status, and trends. Players can ensure positive results for their quarterly and yearly earnings with the help of the complete evaluation of the global Genomics Software market provided in the report.

Unlock Exclusive Market Insights - Customize Your Research Report Now! https://www.qyresearch.in/pre-order-inquiry/service-software-genomics-software-global-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Table of Content

1 Market Overview
1.1 Genomics Software Product Introduction
1.2 Global Genomics Software Market Size Forecast (2020-2031)
1.3 Genomics Software Market Trends & Drivers
1.3.1 Genomics Software Industry Trends
1.3.2 Genomics Software Market Drivers & Opportunity
1.3.3 Genomics Software Market Challenges
1.3.4 Genomics Software Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Competitive Analysis by Company
2.1 Global Genomics Software Players Revenue Ranking (2024)
2.2 Global Genomics Software Revenue by Company (2020-2025)
2.3 Key Companies Genomics Software Manufacturing Base Distribution and Headquarters
2.4 Key Companies Genomics Software Product Offered
2.5 Key Companies Time to Begin Mass Production of Genomics Software
2.6 Genomics Software Market Competitive Analysis
2.6.1 Genomics Software Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Genomics Software Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics Software as of 2024)
2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
3.1 Introduction by Type
3.1.1 On-Premise
3.1.2 Cloud Based
3.2 Global Genomics Software Sales Value by Type
3.2.1 Global Genomics Software Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Genomics Software Sales Value, by Type (2020-2031)
3.2.3 Global Genomics Software Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Health Systems
4.1.2 Research Organizations
4.1.3 Others
4.2 Global Genomics Software Sales Value by Application
4.2.1 Global Genomics Software Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Genomics Software Sales Value, by Application (2020-2031)
4.2.3 Global Genomics Software Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region
5.1 Global Genomics Software Sales Value by Region
5.1.1 Global Genomics Software Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Genomics Software Sales Value by Region (2020-2025)
5.1.3 Global Genomics Software Sales Value by Region (2026-2031)
5.1.4 Global Genomics Software Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Genomics Software Sales Value, 2020-2031
5.2.2 North America Genomics Software Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Genomics Software Sales Value, 2020-2031
5.3.2 Europe Genomics Software Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Genomics Software Sales Value, 2020-2031
5.4.2 Asia Pacific Genomics Software Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Genomics Software Sales Value, 2020-2031
5.5.2 South America Genomics Software Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Genomics Software Sales Value, 2020-2031
5.6.2 Middle East & Africa Genomics Software Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Genomics Software Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Genomics Software Sales Value, 2020-2031
6.3 United States
6.3.1 United States Genomics Software Sales Value, 2020-2031
6.3.2 United States Genomics Software Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Genomics Software Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Genomics Software Sales Value, 2020-2031
6.4.2 Europe Genomics Software Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Genomics Software Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Genomics Software Sales Value, 2020-2031
6.5.2 China Genomics Software Sales Value by Type (%), 2024 VS 2031
6.5.3 China Genomics Software Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Genomics Software Sales Value, 2020-2031
6.6.2 Japan Genomics Software Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Genomics Software Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Genomics Software Sales Value, 2020-2031
6.7.2 South Korea Genomics Software Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Genomics Software Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Genomics Software Sales Value, 2020-2031
6.8.2 Southeast Asia Genomics Software Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Genomics Software Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Genomics Software Sales Value, 2020-2031
6.9.2 India Genomics Software Sales Value by Type (%), 2024 VS 2031
6.9.3 India Genomics Software Sales Value by Application, 2024 VS 2031

7 Company Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Profile
7.1.2 Agilent Technologies Main Business
7.1.3 Agilent Technologies Genomics Software Products, Services and Solutions
7.1.4 Agilent Technologies Genomics Software Revenue (US$ Million) & (2020-2025)
7.1.5 Agilent Technologies Recent Developments
7.2 SAS (JMP Genomics)
7.2.1 SAS (JMP Genomics) Profile
7.2.2 SAS (JMP Genomics) Main Business
7.2.3 SAS (JMP Genomics) Genomics Software Products, Services and Solutions
7.2.4 SAS (JMP Genomics) Genomics Software Revenue (US$ Million) & (2020-2025)
7.2.5 SAS (JMP Genomics) Recent Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Profile
7.3.2 Thermo Fisher Scientific Main Business
7.3.3 Thermo Fisher Scientific Genomics Software Products, Services and Solutions
7.3.4 Thermo Fisher Scientific Genomics Software Revenue (US$ Million) & (2020-2025)
7.3.5 Thermo Fisher Scientific Recent Developments
7.4 QIAGEN Digital Insights
7.4.1 QIAGEN Digital Insights Profile
7.4.2 QIAGEN Digital Insights Main Business
7.4.3 QIAGEN Digital Insights Genomics Software Products, Services and Solutions
7.4.4 QIAGEN Digital Insights Genomics Software Revenue (US$ Million) & (2020-2025)
7.4.5 QIAGEN Digital Insights Recent Developments
7.5 DNASTAR
7.5.1 DNASTAR Profile
7.5.2 DNASTAR Main Business
7.5.3 DNASTAR Genomics Software Products, Services and Solutions
7.5.4 DNASTAR Genomics Software Revenue (US$ Million) & (2020-2025)
7.5.5 DNASTAR Recent Developments
7.6 Fabric Genomics
7.6.1 Fabric Genomics Profile
7.6.2 Fabric Genomics Main Business
7.6.3 Fabric Genomics Genomics Software Products, Services and Solutions
7.6.4 Fabric Genomics Genomics Software Revenue (US$ Million) & (2020-2025)
7.6.5 Fabric Genomics Recent Developments
7.7 Biomatters (Geneious)
7.7.1 Biomatters (Geneious) Profile
7.7.2 Biomatters (Geneious) Main Business
7.7.3 Biomatters (Geneious) Genomics Software Products, Services and Solutions
7.7.4 Biomatters (Geneious) Genomics Software Revenue (US$ Million) & (2020-2025)
7.7.5 Biomatters (Geneious) Recent Developments
7.8 Illumina
7.8.1 Illumina Profile
7.8.2 Illumina Main Business
7.8.3 Illumina Genomics Software Products, Services and Solutions
7.8.4 Illumina Genomics Software Revenue (US$ Million) & (2020-2025)
7.8.5 Illumina Recent Developments
7.9 DNAnexus
7.9.1 DNAnexus Profile
7.9.2 DNAnexus Main Business
7.9.3 DNAnexus Genomics Software Products, Services and Solutions
7.9.4 DNAnexus Genomics Software Revenue (US$ Million) & (2020-2025)
7.9.5 DNAnexus Recent Developments
7.10 Bionano
7.10.1 Bionano Profile
7.10.2 Bionano Main Business
7.10.3 Bionano Genomics Software Products, Services and Solutions
7.10.4 Bionano Genomics Software Revenue (US$ Million) & (2020-2025)
7.10.5 Bionano Recent Developments
7.11 Golden Helix
7.11.1 Golden Helix Profile
7.11.2 Golden Helix Main Business
7.11.3 Golden Helix Genomics Software Products, Services and Solutions
7.11.4 Golden Helix Genomics Software Revenue (US$ Million) & (2020-2025)
7.11.5 Golden Helix Recent Developments
7.12 10x Genomics
7.12.1 10x Genomics Profile
7.12.2 10x Genomics Main Business
7.12.3 10x Genomics Genomics Software Products, Services and Solutions
7.12.4 10x Genomics Genomics Software Revenue (US$ Million) & (2020-2025)
7.12.5 10x Genomics Recent Developments

8 Industry Chain Analysis
8.1 Genomics Software Industrial Chain
8.2 Genomics Software Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Genomics Software Sales Model
8.5.2 Sales Channel
8.5.3 Genomics Software Distributors

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

About US:

QYResearch is a leading global market research and consulting company established in 2007. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

Contact US

QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
Web - https://www.qyresearch.in
Tel: +91-8149736330
Email- ankit@qyresearch.com

This release was published on openPR.